Telix and United Imaging form theranostics collaboration Jun 2, 2026 07:01AM
JPMorgan Starts Telix Pharmaceuticals Ltd (TLX:AU) (TLX) at Overweight Jun 1, 2026 12:55AM
Telix completes enrollment for first-line glioblastoma study May 18, 2026 05:00PM
Telix partners with EDAP and Profound on prostate imaging tech May 15, 2026 06:31AM
Telix study shows cancer imaging drug may detect broader kidney tumors May 4, 2026 05:01PM


Apr 30, 2026 06:53AM H.C. Wainwright Reiterates Buy Rating on Telix Pharmaceuticals Ltd (TLX)
Apr 29, 2026 05:01PM Telix presents dosimetry data for prostate cancer drug candidate
Apr 13, 2026 06:38AM H.C. Wainwright Reiterates Buy Rating on Telix Pharmaceuticals Ltd (TLX)
Apr 13, 2026 06:31AM Regeneron and Telix form $2.1 billion radiopharmaceutical partnership
Apr 10, 2026 06:45AM H.C. Wainwright Reiterates Buy Rating on Telix Pharmaceuticals Ltd (TLX)
Apr 10, 2026 05:30AM FDA accepts Telix brain cancer imaging drug application
Apr 9, 2026 03:57AM Telix adds two non-executive directors to board
Apr 7, 2026 07:46AM H.C. Wainwright Reiterates Buy Rating on Telix Pharmaceuticals Ltd (TLX)
Apr 1, 2026 07:15AM William Blair Shuffles Analyst Conviction List for April 2026
Feb 17, 2026 04:57PM Telix submits European application for brain cancer imaging drug
Jan 26, 2026 09:18AM Citi Opens 90-Day Upside Catalyst Watch on Telix Pharmaceuticals Ltd (TLX:AU) (TLX)
Dec 10, 2025 07:00AM Telix partners with Varian on cancer imaging and radiation therapy
Oct 23, 2025 07:03AM Telix's TLX250-CDx imaging agent included in international renal guidelines
Oct 22, 2025 04:00PM Telix doses first patient in bone pain radiopharmaceutical trial
Oct 4, 2025 04:00PM Why UBS says Q4 is eventful for SMID oncology stocks
Sep 23, 2025 10:15AM CMS grants reimbursement status for Telix's Gozellix prostate imaging agent
Sep 18, 2025 07:17AM Citi Opens 90-Day Upside Catalyst Watch on Telix Pharmaceuticals (TLX)
Sep 18, 2025 06:33AM Citi Starts Telix Pharmaceuticals Ltd (TLX) at Buy
Sep 11, 2025 06:47AM Telix Pharmaceuticals Ltd (TLX) PT Lowered to $20 at H.C. Wainwright
Aug 28, 2025 12:42PM JPMorgan Downgrades Telix Pharmaceuticals Ltd (TLX) to Neutral
Jul 3, 2025 06:37AM H.C. Wainwright Starts Telix Pharmaceuticals Ltd (TLX) at Buy
Apr 7, 2025 06:30AM Telix Pharmaceuticals (TLX) Appoints Paul Schaffer as CTO
Apr 1, 2025 03:31PM Telix Pharmaceuticals (TLX) Announces First Patient Dosed in First-in-Human ZOLAR Trial of TLX300-CDx in Advanced Soft Tissue Sarcoma
Mar 21, 2025 06:35AM Telix Pharmaceuticals (TLX) Announces FDA Approval of Gozellix
Feb 20, 2025 07:30AM Telix Pharmaceuticals Limited (TLX) Reports FY results; offers guidance
Feb 12, 2025 04:43PM Telix (TLX) announces UK approval of Illuccix
Jan 30, 2025 04:58PM Trans-lux Corporation (TLX) Completes Acquisition of Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform
Nov 15, 2024 02:38AM UBS Starts Telix Pharmaceuticals Ltd (TLX) at Buy